Various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals…
Ended Awarded Last action
- Contract number
- HT001418F0183
- Awardee
-
Broughton Pharmaceuticals, LLC UEI J949HUF889Y1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $299,531
Award facts
- Contract value 100% obligated
- $299,531.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$469 | |
| Original award | $300,000 |
About this award
This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, GA. The BPA call is for the provision of various pharmaceutical shortage items, including blood products, oncological pharmaceuticals, and other injectable, oral, and inhalation medications. The contract has a potential value of $299,531.43 and a completion date of September 30, 2018. The contract is a Firm Fixed Price agreement and does not have a set-aside designation. Broughton Pharmaceuticals has a history of providing pharmaceutical products and supplies to government agencies such as the Department of Veterans Affairs, the Defense Health Agency, and the Department of Health and Human Services Indian Health Service through previous contract awards.
Description
Various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products including injectables, orals and medicinal inhalations.
Quick answers
Who was awarded contract HT001418F0183?
HT001418F0183 was awarded to Broughton Pharmaceuticals, LLC by Defense Health Agency (Department of Defense) on May 18, 2018.
How much is contract HT001418F0183 worth?
The government has obligated $299,531 on HT001418F0183.
Is contract HT001418F0183 an order under another contract?
Yes. HT001418F0183 is a BPA call under HT001414A0014, a blanket purchase agreement.
Was contract HT001418F0183 competed?
The extent of competition for HT001418F0183 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award